Biotech

All Articles

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings and...

Lykos are going to ask FDA to reconsider its selection following turndown of MDMA therapy for post-traumatic stress disorder

.Complying with a bad revealing for Lykos Rehabs' MDMA candidate for trauma at a latest FDA advisory...

AN 2 one-halfs headcount, ceases stage 3 trial after information let down

.AN2 Rehabs is actually rethinking its business in reaction to dull midphase data, swearing to lay o...

Merck pays $700M for bispecific, spying autoimmune opening and possibility to challenge Amgen in cancer

.Merck &amp Co. is actually paying $700 million in advance to test Amgen in a blood cancer market. T...

Gilead pays for J&ampJ $320M to leave licensing deal for seladelpar

.With Gilead Sciences about to an FDA choice for its liver illness medicine seladelpar, the business...

' All palms on deck' at Lilly as peers target excessive weight market

.CEO David Ricks may find the firms setting up tents at basecamp responsible for Eli Lilly in an att...

Entero giving up staff, leaving office as well as stopping briefly R&ampD

.Mattress Liquidators has actually transformed Entero Therapies white as a slab. The financial insti...

Exelixis falls ADC after deciding it is actually no match for Tivdak

.Exelixis is surrendering on its own tissue aspect (TF)- targeting antibody-drug conjugate after end...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.3 weeks after Roche's Genentech device left an SHP2 prevention pact, Relay Therapy has actually val...

Stoke's Dravet syndrome med discharged of predisposed professional hold

.Stoke Rehabs' Dravet syndrome drug has been freed from a predisposed grip, clearing the way for the...